Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an antiepileptic presented as an oral dosage form for oral use. It is employed to control various seizure types in patients with epilepsy and is approved for use in the European Union. Levetiracetam Accord is supplied in compliance with international quality standards and is intended for prescription‑only distribution.

GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that reduces neuronal excitability in seizure disorders.

- Partial‑onset seizures: decreases the frequency of focal seizures in patients with epilepsy. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes in generalized seizure disorders. - Myoclonic seizures: reduces myoclonic jerks in patients with juvenile myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Somnolence: increased sleepiness during the day. - Irritability: mood changes or agitation. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare skin blistering condition. - Suicidal thoughts or behavior: emergence of depressive symptoms. - Severe depression or mood disorders. - Blood dyscrasias: abnormal blood cell counts. - Life‑threatening rash: widespread skin eruptions.

Before initiating therapy, clinicians should consider several safety aspects.

- Renal impairment: adjust dose based on creatinine clearance. - Hepatic dysfunction: monitor liver function tests periodically. - History of psychiatric disorders: observe for mood changes or suicidal ideation. - Pregnancy: discuss potential risks with the prescriber, as safety data are limited. - Concomitant CNS depressants: monitor for enhanced sedation or respiratory depression. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levetiracetam may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenytoin: can reduce levetiracetam levels, compromising seizure control. - Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: can potentiate central nervous system depression. - Valproate: monitor for additive effects on seizure control. - Probenecid: may increase levetiracetam levels, requiring dose review.